Skip to main content
Sima Jeha, MD, Pediatric Hematology & Oncology, Memphis, TN, St. Jude Children's Research Hospital

SimaJehaMD

Pediatric Hematology & Oncology Memphis, TN

Professor, Pediatrics, University of Tennessee Health Science Center College of Medicine

Dr. Jeha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jeha's full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 1987 - 1992
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 1983

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2003 - 2025
  • TX State Medical License
    TX State Medical License 1992 - 2009
  • CO State Medical License
    CO State Medical License 1990 - 1995

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Serum ALT Elevations in Survivors of Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study  
    Matthew J Krasin, Sima Jeha, Daniel M Green, Melissa M Hudson, Wayne L Furman, Michael W Bishop, Hepatology

Abstracts/Posters

  • Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor and Molecularly Resistant Acute Lymphoblastic Leukemia (R/R ALL): Updated Analysis of 110 ...
    Sima Jeha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • The Genomic Landscape of Childhood Acute Lymphoblastic Leukemia
    Sima Jeha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Traumatic and Bloody Lumbar Puncture at Diagnosis in Children with Acute Lymphoblastic Leukemia: A St. Jude Total XV and Total Xvi Cohort Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: R... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Join Marlo Thomas During "Yalla, Together for St. Jude" on Feb. 4 at 7 p.m. ET for a Founder's Day Celebration of St. Jude Children's Research Hospital
    Join Marlo Thomas During "Yalla, Together for St. Jude" on Feb. 4 at 7 p.m. ET for a Founder's Day Celebration of St. Jude Children's Research HospitalFebruary 3rd, 2021
  • Join Marlo Thomas During "Yalla, Together for St. Jude" on Feb. 4 at 7 p.m. ET for a Founder's Day Celebration of St. Jude Children's Research Hospital
    Join Marlo Thomas During "Yalla, Together for St. Jude" on Feb. 4 at 7 p.m. ET for a Founder's Day Celebration of St. Jude Children's Research HospitalFebruary 3rd, 2021
  • St. Jude Children’s Research Hospital Clinical Trial Results Reduce Rate of Relapse for Children with Acute Lymphoblastic Leukemia (ALL)
    St. Jude Children’s Research Hospital Clinical Trial Results Reduce Rate of Relapse for Children with Acute Lymphoblastic Leukemia (ALL)October 29th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations